Status:
RECRUITING
Course for Brain Fatigue After Graves' Disease Controlled Study
Lead Sponsor:
Vastra Gotaland Region
Conditions:
Graves Disease
Eligibility:
All Genders
18-72 years
Phase:
NA
Brief Summary
BACKGROUND. Mental fatigue (MF) is common in the most common form of hyperthyroidism, Graves' disease (GD). Clinically, MF is the primary mental symptom in patients with GD and is characterized by dif...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 18-72 years old
- 15-72 months since first Graves' diagnosis
- high free thyroxin and thyroid antibodies (TRAb) at diagnosis
- euthyroid the last 6 months normal thyroid hormone levels at inclusion
- symptoms on MF in connection to Graves diagnosis
- MF-scale ≥10.5 points
- Exclusion criteria:
- other diseases or situations that may be associated with mental fatigue (such as other active inflammatory disease, neurological disease)
- pregnancy
- lactation
- assessment that the patient cannot follow the study protocol.
Exclusion
Key Trial Info
Start Date :
October 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 10 2027
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT06134219
Start Date
October 10 2023
End Date
May 10 2027
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Agneta Lindo
Gothenburg, Sweden, 413 45